NCT07520825 is a NA clinical trial of Photobiomodulation in Hard-to-heal Wounds, sponsored by Umeå University.

Who is sponsoring NCT07520825?

NCT07520825 is sponsored by Umeå University.

What drugs are being tested in NCT07520825?

Interventions in NCT07520825: Photobiomodulation, Standard-of-care ulcer dressing.

What condition does NCT07520825 study?

NCT07520825 studies Hard-to-heal Wounds, Venous Leg Ulcer (VLU), Arterial Leg Ulcer, Pressure Ulcer (PU).

Is NCT07520825 still recruiting?

NCT07520825 is currently active, enrolled. Last updated 9 April 2026.

Last reviewed 2026-04-09 · How we verify

NCT07520825

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Photobiomodulation for Hard-to-heal Ulcers in Frail Older Adults

Active, enrolled NA Last updated 9 April 2026

What this trial tests

NA trial testing Photobiomodulation in Hard-to-heal Wounds in 1,290 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 September 2020

Primary endpoint
30 May 2023

1 May 2027

Quick facts

Lead sponsor	Umeå University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,290
Start date	1 September 2020
Primary completion	30 May 2023
Estimated completion	1 May 2027
Sites	1 location across Sweden

Drugs / interventions tested

Photobiomodulation
Standard-of-care ulcer dressing

Conditions studied

Hard-to-heal Wounds — all drugs for Hard-to-heal Wounds →
Venous Leg Ulcer (VLU) — all drugs for Venous Leg Ulcer (VLU) →
Arterial Leg Ulcer — all drugs for Arterial Leg Ulcer →
Pressure Ulcer (PU) — all drugs for Pressure Ulcer (PU) →

Sponsor

Umeå University

Who can join

18 and older, any sex, with Hard-to-heal Wounds or Venous Leg Ulcer (VLU). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this quasi-experimental prospective study is to evaluate the effectiveness of photobiomodulation treatment on hard-to-heal ulcers of various diagnosed aetiologies in frail older adults, admitted to municipal home healthcare. The study also include evaluation of cost-effectiveness, and healthcare providers experiences of treating frail older adults hard-to-heal ulcers with photobiomodulation treatment in home healthcare.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Photobiomodulation

Trials testing the same drug.

NCT07183267 — Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Year · NA · not yet recruiting
NCT07296068 — Can Acute Photobiomodulation Improve Balance and Cognition in Individuals With Ataxia: a Pilot Feasibility Placebo Rando · NA · not yet recruiting
NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
NCT06984796 — Photobiomodulation on Pain Perception During the Insertion of the T 380 Copper Intrauterine Device (IUD) · NA · not yet recruiting
NCT07425080 — HELIOS Advanced: Human Oocyte Illumination to Enhance Development · NA · recruiting

Other Umeå University trials

Trials by the same sponsor.

NCT07407946 — Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion · NA · recruiting
NCT07346820 — VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation · not yet recruiting
NCT07417358 — Single-Stapled Technique for Colorectal Anastomosis · recruiting
NCT07316426 — Preoptimisation in Ventral Hernia Surgery · NA · recruiting
NCT07170722 — Sub-threshold DRG Stimulation vs Sham in Established Responders · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07520825 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Umeå University
Last refreshed: 9 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07520825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing